Voleon Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Voleon Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,032	Closed	-$322K	–	814
2026 Q1	$322K	Buy	+15,032	New	+$212K	0.01%	660

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Voleon Capital Management's DAWN Position: Q2 2026 in Review

Voleon Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 15,032 shares — an estimated $322K sold.

Voleon Capital Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $322K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Voleon Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Voleon Capital Management sold 15,032 Day One Biopharmaceuticals shares in Q2 2026, an estimated $322K.
Voleon Capital Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Voleon Capital Management's Day One Biopharmaceuticals position peaked at $322K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.